Pages that link to "Q42598676"
Jump to navigation
Jump to search
The following pages link to Douglas Palmer (Q42598676):
Displaying 50 items.
- Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells (Q24530100) (← links)
- Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells (Q24540135) (← links)
- IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells (Q24621753) (← links)
- Tumor-specific Th17-polarized cells eradicate large established melanoma (Q24648032) (← links)
- Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells (Q24651232) (← links)
- Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing (Q27334215) (← links)
- Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance (Q28269352) (← links)
- TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation (Q28589031) (← links)
- Viral sequestration of antigen subverts cross presentation to CD8(+) T cells (Q33455511) (← links)
- Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells (Q33831940) (← links)
- Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts (Q34109953) (← links)
- Th17 cells are long lived and retain a stem cell-like molecular signature (Q34241261) (← links)
- Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity (Q34360174) (← links)
- Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. (Q34422330) (← links)
- Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape (Q34473737) (← links)
- Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. (Q34538613) (← links)
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. (Q34557953) (← links)
- High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation (Q34657652) (← links)
- Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer (Q34703616) (← links)
- Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest (Q34892977) (← links)
- miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. (Q34985536) (← links)
- The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor. (Q34999698) (← links)
- CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. (Q35190928) (← links)
- Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice (Q35223241) (← links)
- Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. (Q35257907) (← links)
- Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells (Q35613477) (← links)
- Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells (Q35638571) (← links)
- IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells (Q35638639) (← links)
- Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. (Q35901034) (← links)
- Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen (Q36111571) (← links)
- Toll-like receptors in tumor immunotherapy (Q36253608) (← links)
- Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. (Q36371632) (← links)
- Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy (Q36430680) (← links)
- Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. (Q36432030) (← links)
- T-cell receptor gene therapy of established tumors in a murine melanoma model (Q36449599) (← links)
- The transcription factor BACH2 promotes tumor immunosuppression. (Q36515031) (← links)
- Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. (Q36562453) (← links)
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy (Q36677310) (← links)
- Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity (Q36693023) (← links)
- Collapse of the tumor stroma is triggered by IL-12 induction of Fas. (Q36984473) (← links)
- Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers. (Q37002020) (← links)
- BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers (Q37032991) (← links)
- Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells (Q37194931) (← links)
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. (Q37200886) (← links)
- MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer (Q37210788) (← links)
- Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma (Q37275309) (← links)
- Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination. (Q37334596) (← links)
- Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. (Q37389018) (← links)
- Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function (Q37455362) (← links)
- Ionic immune suppression within the tumour microenvironment limits T cell effector function. (Q37548587) (← links)